GL3 | Clinical Trials Search

找到 1,440 条关于 “GL3”

需要更精确的结果？

可按分期、招募状态、国家、申办方、年龄和研究类型筛选。

高级筛选临床试验

Insulin Degludec Titration Using Mobile Insulin Dosing System

计划入组 240 人 · 首次发布于 2017 年 3 月 27 日

A RANDOMIZED, MULTINATIONAL, DOUBLE-BLIND, PLACEBO-CONTROLLED AND PARALLEL-GROUP ACTIVE COMPARATOR STUDY TO EXAMINE THE SAFETY, TOLERABILITY AND EFFICACY OF ROFECOXIB OF 50 AND 25 MG FOR THE ACUTE TREATMENT OF MIGRAINE

计划入组 0 人

A Randomized, Double Blind, Parallel Group, Placebo Controlled Outpatient Study to Examine the Safety, Tolerability and Efficacy of Single Oral Doses of Rizatriptan 10 mg and Zolmitriptan 2.5 mg for the Acute Treatment of Migraine.

计划入组 0 人

A Randomized, Double Masked, Parallel Group, Placebo Controlled Outpatient Study to Examine the Safety, Tolerability and Efficacy of Single Oral Doses of Rizatriptan 10 mg and Naratriptan 2.5 mg for the Acute Treatment of Migraine

计划入组 0 人

A Study to Test the Safety and Effectiveness of MK-0974 (Telcagepant) Co-administered With Ibuprofen or Acetaminophen in Patients With Migraines With or Without Aura (MK-0974-046)

计划入组 0 人

Discontinuation One Week Recommendations for GLP-1 Receptor Agonists Prior to Esophagogastroduodenoscopy.

计划入组 140 人 · 首次发布于 2026 年 7 月 30 日

Discontinuation Recommendations for GLP-1 Receptor Agonists Prior to Colonoscopy

计划入组 240 人 · 首次发布于 2026 年 7 月 30 日

Exploring the Influence of Glucagon-like Peptide -1 (GLP-1) Medications on Food Cravings, Food Selection, and Food Intake Following Exposure to Food Advertisements

计划入组 50 人 · 首次发布于 2026 年 4 月 1 日

Evaluation of a Nutritional Intervention With Dietary Supplements in People Who Have Recently Lost Weight: Effects on Body Composition, Emotional Health, and Gut Microbiota

计划入组 70 人 · 首次发布于 2025 年 12 月 8 日

Impact of GLP-1 Receptor Agonist Therapy on Alcohol Pharmacokinetics

计划入组 5 人 · 首次发布于 2026 年 8 月 11 日

第 1 页，共 77 页